Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 13,000 shares at $96.36 ($1.3M) on 2015-08-03, disclosed to the SEC on 2015-08-04.
Scheduled sale ($1.3M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.39 | 2,342 | $223K | 17.9% |
| 2 | $96.36 | 10,658 | $1.0M | 82.1% |
| Total | $96.19 avg | 13,000 | $1.3M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |